CONMED Corporation
CNMD
Positions held
Your positionsCNMD isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- CONMED Corporation operates in the medical devices industry, which is experiencing steady growth driven by an aging population and increasing healthcare spending.
- Revenue increased by 8% compared to the prior quarter, reaching $343 million.
- Operating margin expanded to 10.6%, indicating improved operational efficiency.
- The company has a high debt-to-equity ratio of 80.109, which may raise concerns about financial stability.
- Gross margin slightly decreased to 57.5% from 57.9% in the prior quarter.
- The stock has a trailing P/E ratio of 25.56, suggesting it may be overvalued compared to industry peers.
Fundamentals
| Market cap | $1.35B | Enterprise value | $2.15B | Trailing P/E | 24.38 | Forward P/E | 9.43 |
| PEG | 1.84 | Price / book | 1.30 | Beta | 0.94 | Dividend yield | 0.00% |
| Revenue growth | 0.3% | Earnings growth | 11.2% | Gross margin | 55.6% | Operating margin | 14.6% |
| Profit margin | 4.1% | ROE | 5.5% | ROA | 4.1% | Debt / equity | 0.80 |
| Current ratio | 1.48 | Free cash flow | $131.36M | Analyst recommendation | none | Mean target | $45.50 |
| 52w high | $53.66 | 52w low | $31.44 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $343M | $317M | $373M | $338M | $342M |
| Op margin | 10.6% | 8.0% | 9.8% | 3.5% | 11.1% |
| Net income | $23.1M | $13.8M | $16.7M | $2.9M | $21.4M |
| Gross margin | 57.5% | 57.9% | 58.5% | 49.2% | 55.0% |
| Gross profit | $197M | $183M | $218M | $166M | $188M |
| Operating income | $36.4M | $25.4M | $36.6M | $11.9M | $38.2M |
- Revenue +8% vs prior quarter ($343M vs $317M).
- Gross margin 57.5% (was 57.9% prior quarter).
- Operating margin expanded to 10.6%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $1.4B | $1.3B | $1.2B | $1.0B | — |
| Op margin | 7.5% | 15.3% | 9.7% | 6.7% | — |
| Net income | $47.1M | $132M | $64.5M | -$80.6M | — |
| Gross margin | 54.6% | 56.1% | 54.3% | 54.6% | — |
| Gross profit | $750M | $733M | $676M | $571M | — |
| Operating income | $103M | $200M | $121M | $70.1M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-02 · Surgical Equipment & Consumables - Diversified Stocks Q2 Recap: Benchmarking CONMED (NYSE:CNMD)
2026-10-01 · CONMED Corporation to Report Third Quarter 2026 Financial Results on October 28, 2026
2026-09-24 · 3 Value Stocks That Concern Us
2026-09-21 · Avantor Names Todd Garner as CFO
2026-09-18 · 1 Unpopular Stock That Should Get More Attention and 2 We Turn Down
2026-09-16 · Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
2026-09-08 · Is Cardinal Health Building a New Tech-Enabled Healthcare Platform?
2026-09-03 · Why Is Henry Schein (HSIC) Up 0.9% Since Last Earnings Report?
2026-08-28 · Conmed (CNMD) Up 7.1% Since Last Earnings Report: Can It Continue?
2026-08-26 · CONMED Corporation to Participate in the Wells Fargo 21st Annual Healthcare Conference
2026-08-24 · 3 Reasons to Avoid CNMD and 1 Stock to Buy Instead
2026-08-18 · The Bull Case For CONMED (CNMD) Could Change Following Shift In Regulatory Tailwinds Across Its Surgical Portfolio
Price (daily)
Full chart · RSI · MACD · patterns